These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23616638)
1. Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Sandora TJ; Dolan SA; Harbarth S; Huang SS; McAdam AJ; Milstone AM Clin Chem; 2013 Nov; 59(11):1556-60. PubMed ID: 23616638 [No Abstract] [Full Text] [Related]
2. Screening for multidrug-resistant bacteria as a predictive test for subsequent onset of nosocomial infection. Galoisy-Guibal L; Soubirou JL; Desjeux G; Dusseau JY; Eve O; Escarment J; Ecochard R Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1233-41. PubMed ID: 17080382 [TBL] [Abstract][Full Text] [Related]
3. Infection control procedures for extensively drug-resistant bacteria and related adverse effects: the experience at the Lyon University Hospitals from 2011 to 2017. Gerbier-Colomban S; Dananché C; Marion E; Bénet T; Dupieux C; Dauwalder O; Bryant J; Vanhems P Clin Microbiol Infect; 2019 Jul; 25(7):919-920. PubMed ID: 30797060 [No Abstract] [Full Text] [Related]
4. Nasal swabs collected routinely to screen for colonization by methicillin-resistant Staphylococcus aureus in intensive care units are a sensitive screening test for the organism in clinical cultures. Byrnes MC; Adegboyega T; Riggle A; Chipman J; Beilman G; Reicks P; Boeser K; Irwin E Surg Infect (Larchmt); 2010 Dec; 11(6):511-5. PubMed ID: 20969468 [TBL] [Abstract][Full Text] [Related]
5. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations. Santos RP; Mayo TW; Siegel JD Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial-resistant bacteria in long-term care facilities: infection control considerations. Richards CL; Steele L J Am Med Dir Assoc; 2003; 4(3 Suppl):S110-4. PubMed ID: 12854983 [No Abstract] [Full Text] [Related]
7. The impact of a single ward for cohorting patients with infection due to multidrug-resistant organisms. Stumpfs DJ; de Souza SB; Konkewicz LR; Lovatto CG; da Silva CF; Teixeira Macedo AB; dos Santos RP Infect Control Hosp Epidemiol; 2013 Aug; 34(8):864-5. PubMed ID: 23838234 [No Abstract] [Full Text] [Related]
8. Screening at admission for carrier prevalence of multidrug-resistant organisms in a pediatric unit. Tarchouna M; Ferjani A; Tilouche S; Marzouk M; Bouguila J; Boughamoura L; Boukadida J Am J Infect Control; 2014 Jan; 42(1):88-9. PubMed ID: 24388477 [No Abstract] [Full Text] [Related]
10. Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit. Strich JR; Palmore TN Infect Dis Clin North Am; 2017 Sep; 31(3):535-550. PubMed ID: 28687211 [TBL] [Abstract][Full Text] [Related]
11. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures. Mutters NT; Günther F; Frank U; Mischnik A J Hosp Infect; 2016 Jun; 93(2):191-6. PubMed ID: 27112045 [TBL] [Abstract][Full Text] [Related]
12. [Control of multiresistant bacteria diffusion in institutions]. Blot S Soins Gerontol; 2006; (61):36-8. PubMed ID: 17063854 [No Abstract] [Full Text] [Related]
19. Antibiotic resistance in the intensive care unit. Kollef MH; Fraser VJ Ann Intern Med; 2001 Feb; 134(4):298-314. PubMed ID: 11182841 [TBL] [Abstract][Full Text] [Related]